Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anika Schrade

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chemical Society Reviews|May 30, 2013
Pickering-type stabilized nanoparticles by heterophase polymerizationAnika Schrade, Katharina Landfester, Ulrich Ziener
Langmuir : the ACS Journal of Surfaces and Colloids|September 9, 2015
Inverse Pickering Emulsions with Droplet Sizes below 500 nmSusanne Sihler, Anika Schrade, Zhihai Cao, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 14, 2011
Preparation of raspberry-like nanocapsules by the combination of Pickering emulsification and solvent displacement techniqueAnika Schrade, Zhihai Cao, Katharina Landfester, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|June 14, 2012
Synthesis and characterization of dually labeled Pickering-type stabilized polymer nanoparticles in a downscaled miniemulsion systemBiao Kang, Anika Schrade, Yang Xu, et al.
Macromolecular Bioscience|September 15, 2012
Surface roughness and charge influence the uptake of nanoparticles: fluorescently labeled pickering-type versus surfactant-stabilized nanoparticlesAnika Schrade, Volker Mailänder, Sandra Ritz, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
Hemasphere|July 16, 2024
Refinement of the prognostic impact of somatic <i>CEBPA</i> bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, et al.
Blood Advances|September 30, 2024
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurinFrank G Rücker, Lars Bullinger, Sibylle Cocciardi, et al.
Blood Advances|April 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplicationsHartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Blood|January 6, 2026
Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemiaHartmut Döhner, Daniela Späth, Maral Saadati, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chemical Society Reviews|May 30, 2013
Pickering-type stabilized nanoparticles by heterophase polymerizationAnika Schrade, Katharina Landfester, Ulrich Ziener
Langmuir : the ACS Journal of Surfaces and Colloids|September 9, 2015
Inverse Pickering Emulsions with Droplet Sizes below 500 nmSusanne Sihler, Anika Schrade, Zhihai Cao, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 14, 2011
Preparation of raspberry-like nanocapsules by the combination of Pickering emulsification and solvent displacement techniqueAnika Schrade, Zhihai Cao, Katharina Landfester, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|June 14, 2012
Synthesis and characterization of dually labeled Pickering-type stabilized polymer nanoparticles in a downscaled miniemulsion systemBiao Kang, Anika Schrade, Yang Xu, et al.
Macromolecular Bioscience|September 15, 2012
Surface roughness and charge influence the uptake of nanoparticles: fluorescently labeled pickering-type versus surfactant-stabilized nanoparticlesAnika Schrade, Volker Mailänder, Sandra Ritz, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
Hemasphere|July 16, 2024
Refinement of the prognostic impact of somatic <i>CEBPA</i> bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, et al.
Blood Advances|September 30, 2024
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurinFrank G Rücker, Lars Bullinger, Sibylle Cocciardi, et al.
Blood Advances|April 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplicationsHartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Blood|January 6, 2026
Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemiaHartmut Döhner, Daniela Späth, Maral Saadati, et al.
Pageof 2